Biosense Webster continues PFA approval trend, nabs CE mark for Varipulse
Continuing the spate of regulatory approvals for pulsed field ablation (PFA) devices around the world, Johnson & Johnson’s Biosense Webster Inc. unit secured CE mark for the Varipulse platform for treatment of symptomatic, drug-refractory recurrent paroxysmal atrial fibrillation.
Johnson Biosense Webster Inc Biosense Webster Bioworld Medtech Biosense Webster Inc Face Mark Johnson Amp
Source: bioworld.com